JOURNAL ARTICLE

Úvea e Iris: ¿Qué podemos ver?, ¿Qué debemos hacer?

Ma. Eugenia Lebrero Berna

Year: 2008 Journal:   Canis et felis Vol: 36 (94)Pages: 40-50

Abstract

With the aggravation of environmental pollution, the incidence of infertility is increasing. Ginsenoside Rg1 is a monomer component extracted from Panax ginseng. It has been found that Ginsenoside Rg1 is able to prevent premature ovarian failure and delay testicular senescence. Therefore, we speculate Ginsenoside Rg1 may have great potential to prevent and treat infertility. The aim of this work is to explore whether Ginsenoside Rg1 plays a protective role in the dinbutyl phthalate (DBP)-induced reproductive function injury mice, and to elucidate the potential mechanism. C57BL/6J male mice were administered by DBP with or without Ginsenoside Rg1 treatment and serum, testis and epididymis were collected for further analysis. Sperm analysis, hematoxylin and eosin staining, and serum hormone detection indicated that Ginsenoside Rg1 treatment improved the sperm density and sperm motility, reduced the testicular tissue damage, increased the serum testosterone and luteinizing hormone levels, and decreased the serum follicle-stimulating hormone level in DBP-induced mice. Furthermore, Ginsenoside Rg1 treatment upregulated expression levels of spermatogenesis-related protein, Cx43, E-cadherin, p-PI3K, p-Akt, and mTOR in the mice treated by DBP, observed by using a immunohistochemistry assay, a real-time quantitative PCR assay, and a western blot analysis. The present study reveals that Ginsenoside Rg1 may exert anti-DBP-induced reproductive function injury in C57BL/6J mice. In addition, the protect role of Ginsenoside Rg1 in spermatogenesis may be associated with the regulation of reproductive hormones, upregulation of spermatogenic associated proteins expression, restoration of the gap junctions, and the activation of PI3K/Akt/mTOR signaling pathways.

Keywords:
Humanities IRIS (biosensor) Philosophy Computer science Artificial intelligence

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
35
Refs
0.01
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Ocular Surface and Contact Lens
Health Sciences →  Medicine →  Public Health, Environmental and Occupational Health
Retinal and Optic Conditions
Health Sciences →  Medicine →  Ophthalmology
Intraocular Surgery and Lenses
Health Sciences →  Medicine →  Ophthalmology

Related Documents

JOURNAL ARTICLE

¿Qué podemos hacer, y qué podemos hacer diferente?... ¡empecemos por colaborar!

Corina González-WeilRoberto Morales Aguilar

Journal:   Revista de Innovación en Enseñanza de las Ciencias Year: 2020 Vol: 4 (2)
JOURNAL ARTICLE

Patrimonio en pedazos: Qué perdemos y qué podemos hacer

Marco Antonio GiovannettiAna IgaretaVerónica S. Lema

Journal:   El Servicio de Difusión de la Creación Intelectual (National University of La Plata) Year: 2005 Pages: 11-20
JOURNAL ARTICLE

Automedicación en España. ¿Qué podemos hacer?

MJ Jubete Vázquez

Journal:   Atención Primaria Year: 2004 Vol: 34 (8)Pages: 445b-446
JOURNAL ARTICLE

Se aprende poco ¿qué podemos hacer?

Dolors Quinquer Vilamitjana

Journal:   Aula de innovación educativa Year: 2006 Vol: 77 (151)Pages: 53-55
© 2026 ScienceGate Book Chapters — All rights reserved.